RAD-140 vs Testosterone for weight loss
Short answer: For weight loss, users rate them about the same: 92% report improvement with RAD-140 (51 reports) and 93% with Testosterone (45 reports).
RAD-140 has 0 meta-analyses and 0 randomized trials on PubMed; Testosterone has 75 and 125.
Based on 684 reports about RAD-140 and 822 about Testosterone. Not medical advice.
| RAD-140 SARM | Testosterone Medication | |
|---|---|---|
| User score | 44 | 54 |
| Verdict | Mixed | Mostly positive |
| Positive of reports that state an outcome | 42% | 77% |
| Reports | 684 | 822 |
| Research | DResearch: None | AResearch: Strong |
| Meta-analyses / RCTs | 0 / 0 | 75 / 125 |
| Mainly used for | ||
| Weight loss % reporting improvement | 92% (51) | 93% (45) |
| Appetite % reporting improvement | 56% (9) | — |
| Focus % reporting improvement | 17% (6) | 82% (28) |
| Energy % reporting improvement | 41% (51) | 92% (76) |
| Sleep % reporting improvement | 3% (39) | 79% (19) |
| Anxiety % reporting improvement | 7% (15) | 80% (25) |
| Mood % reporting improvement | 37% (52) | 88% (104) |
| Memory % reporting improvement | 100% (2) | 100% (2) |
| Performance % reporting improvement | 93% (296) | 97% (149) |
| Recovery % reporting improvement | 96% (28) | 91% (23) |
| Pain & inflammation % reporting improvement | 17% (12) | 67% (6) |
| Digestion % reporting improvement | 0% (3) | — |
| Libido % reporting improvement | 42% (38) | 93% (70) |
| Hormones % reporting improvement | 5% (62) | 90% (91) |
| Heart & lipids % reporting improvement | 6% (32) | 62% (8) |
| Skin & hair % reporting improvement | 0% (11) | 40% (5) |
| Longevity % reporting improvement | — | 50% (2) |
| Common side effects | suppression, hair loss, fatigue, insomnia | suppression, hair loss, acne, water retention |
| Typical dose reported | Not listed | 200 mg / weekly |
RAD-140Full RAD-140 profile →
What a user said
“I did put on decent size and I feel a lot fuller. My strength and endurance has gone up tremendously. Side effects - Shedding of hair, anxiety...”
TestosteroneFull Testosterone profile →
Latest review conclusion
The guidelines also provide recommendations regarding identification of patients, dosing, monitoring, and follow-up. This Practice Pearl will discuss evidence-based testosterone therapy for management of HSDD in postmenopausal women.
Menopause, 2023 ↗What a user said
“Feel the best I've ever felt in my life. TRT and peptides have been game changers for me!”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate